SCHEMBL3827087

SCHEMBL3827087

CCOCC=Cc1ccc(-c2nc(-c3ccc(OC)cc3)c[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.44
▸ PDGFRB P09619 1/20 0.37
▸ KDM4E B2RXH2 6/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HDAC3 O15379 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC10 Q969S8 1/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ HDAC9 Q9UKV0 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MCHR1 Q99705 2/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3827085 1.00 ABCB1 (0.44) ABCB1PDGFRBKDM4EMAPTHDAC3
SCHEMBL13679681 0.84 ABCB1 (0.43) ABCB1KDM4EMAPTALDH1A1NPC1
SCHEMBL13679752 0.82 ABCB1 (0.48) ABCB1
SCHEMBL13679704 0.82 ABCB1 (0.42) ABCB1KDM4EMAPTNPC1RAB9A
SCHEMBL13679705 0.82 ABCB1 (0.67) ABCB1
SCHEMBL13679748 0.81 ABCB1 (0.52) ABCB1
SCHEMBL13679694 0.80 ABCB1 (0.40) ABCB1PDGFRBKDM4EMAPTALDH1A1
SCHEMBL11740126 0.79 KDM4E (0.52) ABCB1KDM4EALDH1A1NPC1RAB9A
SCHEMBL11740132 0.79 KDM4E (0.52) ABCB1KDM4EALDH1A1NPC1RAB9A
SCHEMBL11771726 0.79 KDM4E (0.50) PDGFRBKDM4EMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-0999835-A4 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORP (US) 2004-08-25 — — EP disclosed
EP-0999835-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS Ontogen Corporation (US) 2000-05-17 — — EP disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 — — WO disclosed
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback